News
Gene therapies have seen a drop in investor interest lately. Despite this, Kriya Therapeutics seems to be attracting funds in ...
Discover how in some communities around the world, the prevalence of rare diseases is higher due to factors like cousin ...
As the release of a CRL declining Lykos' therapy generates a strong reaction from MAPS, delve into what this new transparency ...
Learn how multichain biotherapeutics overcome manufacturing challenges with advanced expression vector design.
As radiopharma is gaining momentum, read our interview with Dr. Delpassand, the CEO of RadioMedix's, an established company ...
Once thought to be under control, yellow fever is making an alarming comeback, and the numbers are climbing. With treatment ...
Kriya Therapeutics, Strand Therapeutics, and Minghui Pharmaceutical bagged the biggest biotech funding rounds overall in ...
As September marks the beginning of Blood Cancer Awareness Month, delve into what is being developed in the biotech pipelines.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results